 Market.webp)
Extracorporeal Shock Wave Lithotripsy (ESWL) Market size is estimated to cross USD 1 billion by the end of 2035, growing at a CAGR of 6% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of extracorporeal shock wave lithotripsy was over USD 400 million. The major factor attributed to the expansion of the market is the rising cases of kidney stones among the global population owing to the engagement in a sedentary lifestyle and consumption of a high amount of fatty and processed food items. Recent statistics stated that the prevalence of kidney stones varies from region to region. For instance, in 2022 it was calculated that the prevalence rate of kidney stones is almost 1-5% in Asia, 5-9% in Europe, and 7-15% in North America. At the same time, approximately 20% of the population in Saudi Arabia and only 4% population in China were diagnosed with kidney stones.
In addition to kidney stones, the global extracorporeal shock wave lithotripsy (ESWL) market is also estimated to increase owing to the rise in ureter stones and gallstones. Also, the rising preference for minimally invasive procedures is expected to increase the utilization rate of extracorporeal shock wave lithotripsy (ESWL) for destructing of hardened masses such as kidney stones, bezoars, and gallstones during the forecast period. Furthermore, the escalation in patient awareness of recent technological advancements in the healthcare industry along with the high investments made in the medical devices sector is expected to drive market growth in the upcoming years. Additionally, the increasing awareness level about the advantages of extracorporeal shock wave lithotripsy (ESWL) which includes minimal invasiveness, reduced pain, shorter hospital stay, quicker recovery time, and enhanced overall patients experience is projected to create a positive outlook for market expansion and impetus a significant revenue generation in the forecast period.
Growth Drivers
Growing Cases of Gallstones Among the Global Population – Owing to the adoption of unhealthy lifestyles, people across the globe are being diagnosed with gallstones every day. The most effective way of removing gallstones is considered to be extracorporeal shock wave lithotripsy (ESWL) as per medical professionals. Thus, with the increase in the prevalence of gallstones in the world, the adoption of extracorporeal shock wave lithotripsy (ESWL) for treatment processes is also expected to increase rapidly during the forecast period. For instance, recent reports published in 2022 stated that gallstones affect almost 10 to 15 million people in the North American region every year. Also, in 2018, more than 295,000 cases of gallstone cancer were recorded in 2018 in the world.
The Surge in Obesity – Obesity is a disease that is considered to impact the heart, liver, kidneys, joints, and reproductive systems in a negative way which ultimately propels the growth of stones in human bodies. Thus, the rising number of people with obesity is a positive factor for the utilization rate of extracorporeal shock wave lithotripsy (ESWL) in the next few years. The World Health Organization (WHO) stated that around 1 billion people out of which 650 million are adults, 340 million are adolescents, and 39 million are children are categorized as obese worldwide.
Increased Number of Diseases Being Performed Annually Worldwide – As a result of rising diseases and illnesses, a high number of surgeries are being performed across hospitals present across the world. This factor is anticipated to increase the adoption rate of extracorporeal shock wave lithotripsy (ESWL) during surgical procedures. The National Library of Medicine stated that approximately 310 million major surgeries are performed each year worldwide. Out of these, around 40 to 50 million surgeries are performed in the United States and around 20 million in the European region.
Escalation in the Investments for Developing Healthcare Devices - The data revealed by the India Brand Equity Foundation (IBEF) stated that in FY20, the foreign investments in the Indian medical devices sector increased to USD 301 million from USD 151 million in FY19, which indicates a 98% increment.
Rising Focus on Bringing Advancement in the Healthcare Industry - For instance, investment in medical and health research and development (R&D) in the United States (U.S.) increased by 11% to around USD 245 billion in 2020 from previous years.
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~6% |
|
Base Year Market Size (2022) |
~ USD 400 Million |
|
Forecast Year Market Size (2035) |
~ USD 1 Billion |
|
Regional Scope |
|
Application (Kidney Stones, Biliary Calculi, Salivary Stones, Pancreatic Stones)
The global extracorporeal shock wave lithotripsy (ESWL) market is segmented and analyzed for demand and supply by application into kidney stones, biliary calculi, salivary stones, pancreatic stones, and others. Out of these, the kidney stones segment is anticipated to hold the largest share with a market share of ~43% by the end of 2035. This can be accounted for by the high usage of ESWL for breaking kidney stones into small pieces so that they can easily travel through the urinary tract and pass from the body. Apart from this, shock wave lithotripsy also helps in reducing symptoms (such as pain) and allows people to pass kidney stones on their own, which is also assessed to boost the market segment growth in the future. In addition, the rising cases of kidney stones that require surgical procedures are also projected to bring lucrative growth opportunities for segment growth. For instance, it was estimated in 2022, that around 10-12% of kidney stone cases across the globe require surgical removal.
End-user (Hospitals, Clinics, Radiology Labs)
The global extracorporeal shock wave lithotripsy (ESWL) market is also segmented and analyzed for demand and supply by end-user in hospitals, clinics, radiology labs, and others. Out of these segments, the hospital segment is projected to garner the highest market share of ~38% and a notable revenue generation during the forecast period. The major factors attributed to the growing segment size are the rising number of hospitals across the globe and the availability of features and facilities for the proper conduction of extracorporeal shock wave lithotripsy (ESWL) treatment. For instance, there were over 8,000 hospitals in Japan as of 2020. Korea, by contrast, had about 4,000 hospitals. In addition, there were more than 6000 hospitals in the United States. Also, the preference of hospitals for treatment as the result of trained medical staff and professionals for proper use of extracorporeal shock wave lithotripsy (ESWL) during surgeries is estimated to expand the segment size in the upcoming years.
Our in-depth analysis of the global market includes the following segments:
|
By Type |
|
|
By Application |
|
|
By End User |
|
North American Market Forecast
The North American extracorporeal shock wave lithotripsy (ESWL) market, amongst the market in all the other regions, is projected to hold the largest market share of ~32% by the end of 2035. The growth of the market can be attributed to the presence of a large number of diabetic and obese patients who are prone to the development of kidney stones and gallstones which is estimated to increase the requirement of extracorporeal shock wave lithotripsy (ESWL) for treatment. According to the American Diabetes Association, 37.3 million Americans in 2019 were suffering from diabetes, with about 1.9 million people experiencing type 1 diabetes, including about 244,000 children. Further, the presence of a strong healthcare network in the region, along with the availability of supportive policies by the regulatory bodies that promote the market players to develop advanced medical products and treatments are also anticipated to contribute to the market growth in the region. In addition, the region's expanding healthcare industry and rising commercialization of medical products are also anticipated to boost market growth during the forecast period.
APAC Market Statistics
On the other hand, the market in the Asia Pacific region is also estimated to garner a significant market share of ~23% with a steady CAGR value by the end of the forecast value. The burgeoning geriatric population who are more prone to develop stones in the body and the presence of a large pool of patients in the region is majorly contributing positively to market growth. In addition to other, the expansion of ASEAN and Japan digital advertising in pharma and medical equipment is also estimated to increase the awareness level of extracorporeal shock wave lithotripsy (ESWL) among the population and aid the expansion of the market in the region.
Europe Market Forecast
Further, the European market, amongst the market in all the other regions is also projected to hold a noteworthy share of the market by the end of the analysis period. The factors that are expected to contribute positively to market expansion in the region are rising research and development activities along with the proven success in the development of extracorporeal shock wave lithotripsy (ESWL) as an efficient treatment method. In addition, the rising prevalence of various types of chronic, cardiovascular, and non-communicable diseases and disorders among the European people is also estimated to create a favorable outlook for market growth during the forecast period.
 Market Size.webp)
Karl Storz Gmbh and Co. KG received clearance from the U.S. Food and Drug Administration (FDA) for MODULITH SLX-F2 extracorporeal shock wave lithotripter. With this device, children over the age of three years suffering from stone disease can now be treated non-invasively.
Dornier MedTech GmbH launched UroX, which is a community that connects professionals from various disciplines to cultivate innovative solutions and solve complex challenges in urology.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?